MeVis Medical Solutions AG (XETRA:M3V) — Stock Price
MeVis Medical Solutions AG (XETRA:M3V) is currently trading at €23.60 EUR, up 0.00% today. Over the past 52 weeks, shares have ranged between €22.20 and €26.40. This page tracks MeVis Medical Solutions AG's live share price on the XETRA exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see M3V market cap overview.
MeVis Medical Solutions AG (M3V) Stock Price Chart — Daily History & Trading Volume
The chart below tracks MeVis Medical Solutions AG's daily closing share price and trading volume on the XETRA exchange over the past year, giving a clear view of recent price momentum and liquidity.
MeVis Medical Solutions AG Income Statement — Revenue, Profit & Earnings by Year
MeVis Medical Solutions AG's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Revenue | €16.06 Million | €16.97 Million | €17.34 Million | €18.76 Million | €16.21 Million |
| Cost of Revenue | €368.70K | €489.67K | €10.34 Million | €746.56K | €436.85K |
| Gross Profit | €15.69 Million | €16.48 Million | €7.00 Million | €18.02 Million | €15.78 Million |
| Research & Development | — | — | — | — | — |
| SG&A | €508.00K | €489.00K | €442.00K | €444.00K | €730.00K |
| Total Operating Expenses | €13.35 Million | €12.48 Million | €558.96K | €11.55 Million | €10.75 Million |
| Operating Income | €2.34 Million | €4.00 Million | €6.44 Million | €6.29 Million | €6.45 Million |
| EBITDA | €3.43 Million | €4.82 Million | €5.17 Million | €7.97 Million | €4.77 Million |
| EBIT | €3.28 Million | €4.69 Million | €5.08 Million | €7.88 Million | €4.64 Million |
| Interest Expense | €577.00 | €19.62K | €42.82K | €3.85K | €10.82K |
| Income Before Tax | €3.28 Million | €4.69 Million | €5.03 Million | €7.88 Million | €4.63 Million |
| Income Tax Expense | €113.00K | €126.40K | €114.18K | €87.11K | €85.00K |
| Net Income | €3.17 Million | €4.56 Million | €4.92 Million | €7.79 Million | €4.55 Million |
MeVis Medical Solutions AG Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes MeVis Medical Solutions AG's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | €25.89 Million | €26.48 Million | €28.05 Million | €31.20 Million | €27.53 Million |
| Total Current Assets | €9.05 Million | €9.55 Million | €11.37 Million | €14.50 Million | €10.87 Million |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | — | — | €-16.23 Million | €-16.23 Million | €-16.23 Million |
| Net Receivables | €2.28 Million | €2.77 Million | €3.33 Million | €4.74 Million | €2.80 Million |
| Inventory | — | — | €-18.95K | €133.44K | €100.20K |
| Property, Plant & Equipment | €308.77K | €315.23K | €146.06K | €162.02K | €121.79K |
| Goodwill | — | — | — | — | — |
| Total Liabilities | €8.06 Million | €8.66 Million | €10.23 Million | €13.38 Million | €9.71 Million |
| Total Current Liabilities | €5.72 Million | €6.36 Million | €6.85 Million | €9.67 Million | €6.65 Million |
| Long-term Debt | — | — | — | — | — |
| Net Debt | €-6.52 Million | €-6.53 Million | €-7.74 Million | €-9.32 Million | €-7.62 Million |
| Total Stockholder Equity | €17.83 Million | €17.83 Million | €17.83 Million | €17.83 Million | €17.83 Million |
| Retained Earnings | €4.54 Million | €4.54 Million | €4.54 Million | €4.54 Million | €4.54 Million |
MeVis Medical Solutions AG Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how MeVis Medical Solutions AG generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | €3.88 Million | €3.15 Million | €5.85 Million | €4.86 Million | €9.13 Million |
| Capital Expenditures | €140.43K | €301.91K | €79.72K | €133.10K | €50.86K |
| Free Cash Flow | €3.74 Million | €2.84 Million | €5.77 Million | €4.72 Million | €9.08 Million |
| Investing Cash Flow | €945.46K | €906.80K | €989.98K | €58.66K | €111.63K |
| Financing Cash Flow | €-4.56 Million | €-4.92 Million | €-7.79 Million | €-4.55 Million | €-5.70 Million |
| Dividends Paid | €4.56 Million | €4.92 Million | €7.79 Million | €4.55 Million | €5.70 Million |
| Stock-Based Compensation | — | — | — | — | — |
| Depreciation | €146.90K | €132.74K | €95.84K | €93.05K | €125.51K |
| Change in Cash | €-4.18K | €-1.22 Million | €-1.58 Million | €1.70 Million | €3.67 Million |
MeVis Medical Solutions AG Earnings History — EPS Actual vs. Analyst Estimates
Track MeVis Medical Solutions AG's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| May 25, 2026 | — | — | — |
| Jan 26, 2026 | — | — | — |
| Aug 28, 2025 | 0.00 | 0.00 | — |
| May 27, 2025 | 1.32 | — | — |
| Jan 30, 2025 | 1.04 | 0.00 | — |
| Nov 27, 2024 | 0.00 | 0.00 | — |
| Sep 04, 2024 | 0.00 | 0.00 | — |
| May 27, 2024 | 0.00 | 0.00 | — |